Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agments. [electronic resource]
- Cancer research Dec 1995
- 5721s-5725s p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.